Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Ader,
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
2022, Pubmed
Ader,
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
2022,
Pubmed
Adhikari,
Critical care and the global burden of critical illness in adults.
2010,
Pubmed
Agarwal,
A living WHO guideline on drugs for covid-19.
2020,
Pubmed
Beigel,
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
2020,
Pubmed
Beigel,
Remdesivir for the Treatment of Covid-19 - Final Report.
2020,
Pubmed
Donnelly,
Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System.
2021,
Pubmed
Estcourt,
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
2021,
Pubmed
Ford,
Pragmatic Trials.
2016,
Pubmed
French,
Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic - United States, July 2020-July 2021.
2021,
Pubmed
Goldman,
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
2020,
Pubmed
Horby,
Dexamethasone in Hospitalized Patients with Covid-19.
2021,
Pubmed
Lee,
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis.
2021,
Pubmed
Lee,
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
2021,
Pubmed
Mahajan,
Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study.
2021,
Pubmed
Murthy,
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
2021,
Pubmed
Naylor,
Canadian federal-provincial/territorial funding of universal health care: fraught history, uncertain future.
2020,
Pubmed
Pan,
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
2021,
Pubmed
Rochwerg,
Remdesivir for severe covid-19: a clinical practice guideline.
2020,
Pubmed
Rubin,
Striving for Diversity in Research Studies.
2021,
Pubmed
Spinner,
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
2020,
Pubmed
Verma,
Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area.
2021,
Pubmed
WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection,
A minimal common outcome measure set for COVID-19 clinical research.
2020,
Pubmed
Wang,
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
2020,
Pubmed
Wunsch,
Variation in critical care services across North America and Western Europe.
2008,
Pubmed
Yehya,
Reappraisal of Ventilator-Free Days in Critical Care Research.
2019,
Pubmed
Yusuf,
Interpreting Geographic Variations in Results of Randomized, Controlled Trials.
2016,
Pubmed
